FibrosIX
East Lansing
About FibrosIX
FibrosIX is a biotechnology company develops drugs to prevent lung fibrosis in cancer patients. The company was founded in 2016 and is headquartered in East Lansing, Michigan.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Estimated revenue: Less than $1M
- Total funding: $256.0K
- Funding stage: Seed
- Last round: Grant (Feb 2021)
- Website: fibrosix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/fibrosix-69988 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.